Naturally Occurring Analogs of Lysophosphatidic Acid Elicit Different Cellular Responses through Selective Activation of Multiple Receptor Subtypes-Reference-Cited by-同舟云学术

Naturally Occurring Analogs of Lysophosphatidic Acid Elicit Different Cellular Responses through Selective Activation of Multiple Receptor Subtypes

Published:1998-12-01 Issue:6 Volume:54 Page:979-988
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Fischer David J.,Liliom Károly,Guo Zhong,Nusser Nóra,Virág Tamás,Murakami-Murofushi Kimiko,Kobayashi Susumu,Erickson James R.,Sun Guoping,Miller Duane D.,Tigyi Gábor

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid

2. Molecular Cloning of the Human Edg2 Protein and Its Identification as a Functional Cellular Receptor for Lysophosphatidic Acid

3. Differential regulation of extracellular signal-regulated protein kinase 1 and Jun N-terminal kinase 1 by Ca2+ and protein kinase C in endothelin-stimulated Rat-1 cells

4. Adenylyl cyclases and the interaction between calcium and cAMP signalling

5. Role of Tyrosine Kinase Activity of Epidermal Growth Factor Receptor in the Lysophosphatidic Acid-stimulated Mitogen-activated Protein Kinase Pathway

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Cyclic Phosphatidic Acid and Other Potential Therapeutic Targets for Treating Osteoarthritis;Biomedicines;2023-10-14

2. Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer;Pharmacology & Therapeutics;2023-05

3. Expression regulation mechanisms and biological functionsof Autotaxin;SCIENTIA SINICA Vitae;2022-08-01

4. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?;Cells;2021-08-11

5. Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential;Journal of Lipid Research;2019-03